Updated survival analysis of a randomized study of lapatinib alone or in combination with trastuzumab in women with HER2-positive metastatic breast cancer progressing on trastuzumab therapy. - Blackwell,K.L.; Burstein,H.J.; Sledge,G.W. (Cancer Res, 2009)